Radiopharm Theranost...
ASX:RAD
$ 0,02
$0,00 (0,00%)
0,02 $
$0,00 (0,00%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
0%
3-year Growth Rate
R
1/2
3-year Risk Analysis
O
-100%
Outlook 12/26
W
7,76%
Margin of safety
T
400%
Analyst Price Target
H
DOWN
50-week EMA Trend

It is not possible to show the GROWTH analysis for a period of five years. Showing the analysis for a period of three years instead.

Company Info

EPS Growth 5Y
44,97%
Revenue growth 5Y
65,34%
Price growth 5Y
-94,67%
Market Cap
$0,08 B
Long-Term Debt
$0,00 B
Quarterly earnings
05/29/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number

Radiopharm Theranostics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$0,10
400%
400
Last Update: 04/11/2026
Analysts: 2

Highest Price Target $0,15

Average Price Target $0,10

Lowest Price Target $0,06

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Radiopharm Theranostics
ASX:RAD
-94,67% -94,67% 0,00% 0,00% 1/2 -100,00% 7,76% 400,00% DOWN
×